Vaccine Contracts

Moderna’s COVID-19 vaccine uses messenger RNA (mRNA) technology. Unlike traditional vaccines, which often use weakened or inactivated virus, mRNA vaccines work by instructing cells to produce a spike protein that triggers an immune response. In addition, Moderna offers a RSV vaccine, mRESVIA, to protect adults aged 60 or older against lower respiratory tract disease caused by respiratory syncytial virus.

The Align Healthcare Partners & Moderna agreement gives Members on-invoice savings on both the COVID-19 and RSV vaccine.

• Spikevax: Vaccine that helps prevent COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older

• mRESVIA: Vaccine used to protect adults aged 60 or older against lower respiratory tract disease caused by respiratory syncytial virus (RSV)

Resources:

Ordering Methods

https://modernadirect.com/

Coding for Reimbursement

https://reimbursement.modernatx.com/